Nexxa.ai | $4,400,000 | (Jul 22, 2025)
Litero AI | $800,000 | (Jul 22, 2025)
xLight Inc. | $40,000,000 | (Jul 22, 2025)
Certified by Founder
Lodge
GC Therapeutics
start up
United States
- Cambridge, MA
- 24/09/2024
- Series A
- $65,000,000
GC Therapeutics Inc. (GCTx) uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability. We dictate cells fates in a single step and have validated cells for many applications. We have also developed SuperCells™ by tailoring cells for specific diseases.
The core technology of GCTx was conceived, invented and perfected in Professor George Church’s lab at Harvard Medical School. We are a group of passionate biologists and tissue engineers whose goal is to bring this breakthrough approach to patients.
- Industry Biotechnology Research
- Website https://www.gc-tx.com/
- LinkedIn https://www.linkedin.com/company/gctx/
Radical AI | $55,000,000 | (Jul 22, 2025)
LeadStory | $2,750,000 | (Jul 22, 2025)
Xelix | $160,000,000 | (Jul 22, 2025)
Toduba | $4,090,457 | (Jul 22, 2025)
Alix | $20,000,000 | (Jul 22, 2025)
Ovasave | $1,200,000 | (Jul 22, 2025)
Magentic | $5,500,000 | (Jul 22, 2025)
WattCarbon | Undisclosed Amount | (Jul 18, 2025)